These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9345170)

  • 1. Audit of prenatal diagnosis for haemoglobin disorders in the United Kingdom: the first 20 years.
    Modell B; Petrou M; Layton M; Varnavides L; Slater C; Ward RH; Rodeck C; Nicolaides K; Gibbons S; Fitches A; Old J
    BMJ; 1997 Sep; 315(7111):779-84. PubMed ID: 9345170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Informed choice in genetic screening for thalassaemia during pregnancy: audit from a national confidential inquiry.
    Modell B; Harris R; Lane B; Khan M; Darlison M; Petrou M; Old J; Layton M; Varnavides L
    BMJ; 2000 Feb; 320(7231):337-41. PubMed ID: 10657326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A national register for surveillance of inherited disorders: beta thalassaemia in the United Kingdom.
    Modell B; Khan M; Darlison M; King A; Layton M; Old J; Petrou M; Varnavides L
    Bull World Health Organ; 2001; 79(11):1006-13. PubMed ID: 11731807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal screening for haemoglobin disorders.
    Petrou M; Modell B
    Prenat Diagn; 1995 Dec; 15(13):1275-95. PubMed ID: 8710767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Audit of process of antenatal screening for sickle cell disorders at a north London hospital.
    Neuenschwander H; Modell B
    BMJ; 1997 Sep; 315(7111):784-5. PubMed ID: 9345171
    [No Abstract]   [Full Text] [Related]  

  • 6. A survey of current United Kingdom practice for antenatal screening for inherited disorders of globin chain synthesis. UK Forum for Haemoglobin Disorders.
    Bain BJ; Chapman C
    J Clin Pathol; 1998 May; 51(5):382-9. PubMed ID: 9708206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivering genetic screening to the community.
    Modell B
    Ann Med; 1997 Dec; 29(6):591-9. PubMed ID: 9562530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethical implications and practical considerations of ethnically targeted screening for genetic disorders: the case of hemoglobinopathy screening.
    Hinton CF; Grant AM; Grosse SD
    Ethn Health; 2011; 16(4-5):377-88. PubMed ID: 21797724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carrier screening for thalassemia and hemoglobinopathies in Canada.
    Langlois S; Ford JC; Chitayat D; ;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):950-959. PubMed ID: 19038079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between maternal haemoglobin concentration and birth weight in different ethnic groups.
    Steer P; Alam MA; Wadsworth J; Welch A
    BMJ; 1995 Feb; 310(6978):489-91. PubMed ID: 7888886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Audit of prenatal diagnosis for hemoglobin disorders in the United Kingdom. The first twenty years.
    Modell B; Petrou M; Layton M; Varnavides L; Moisely C; Ward RH; Rodeck C; Nicolaides K; Fitches A; Old J
    Ann N Y Acad Sci; 1998 Jun; 850():420-2. PubMed ID: 9668572
    [No Abstract]   [Full Text] [Related]  

  • 12. A multidisciplinary approach for improving services in primary care: randomised controlled trial of screening for haemoglobin disorders.
    Modell M; Wonke B; Anionwu E; Khan M; Tai SS; Lloyd M; Modell B
    BMJ; 1998 Sep; 317(7161):788-91. PubMed ID: 9740569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of health services by children and young people according to ethnicity and social class: secondary analysis of a national survey.
    Cooper H; Smaje C; Arber S
    BMJ; 1998 Oct; 317(7165):1047-51. PubMed ID: 9774288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of haemoglobinopathies at premarital health screening in Dohuk, Iraq: implications for a regional prevention programme.
    Al-Allawi NA; Al-Dousky AA
    East Mediterr Health J; 2010 Apr; 16(4):381-5. PubMed ID: 20795420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of a school screening programme for carriers of haemoglobin disease.
    Lena-Russo D; Badens C; Aubinaud M; Merono F; Paolasso C; Martini N; Mattei JF
    J Med Screen; 2002; 9(2):67-9. PubMed ID: 12133925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carrier screening and prenatal diagnosis of hemoglobinopathies. A study of indigenous and immigrant couples in northern Greece, over the last 5 years.
    Theodoridou S; Alemayehou M; Prappas N; Karakasidou O; Aletra V; Plata E; Tsaftaridis P; Karababa P; Boussiou M; Sinopoulou K; Hatzi A; Voskaridou E; Loutradi A; Manitsa A
    Hemoglobin; 2008; 32(5):434-9. PubMed ID: 18932067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal diagnosis of hemoglobinopathies in Ontario, Canada.
    Basran RK; Patterson M; Walker L; Nakamura LM; Eng B; Chui DH; Waye JS
    Ann N Y Acad Sci; 2005; 1054():507-10. PubMed ID: 16339708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of fetal diagnostic testing on birth-rate of thalassaemia major in Britain.
    Modell B; Petrou M; Ward RH; Fairweather DV; Rodeck C; Varnavides LA; White JM
    Lancet; 1984 Dec; 2(8416):1383-6. PubMed ID: 6150377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An analysis of relative costs and potential benefits of different policies for antenatal screening for beta thalassaemia trait and variant haemoglobins.
    Phelan L; Bain BJ; Roper D; Jury C; Bain K
    J Clin Pathol; 1999 Sep; 52(9):697-700. PubMed ID: 10655995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.